In This Section

AACR Congratulates Raymond N. DuBois, MD, PhD, FAACR, on His New Role at The Mark Foundation for Cancer Research

PHILADELPHIA – The American Association for Cancer Research (AACR) today congratulated Raymond N. DuBois, MD, PhD, FAACR, on his appointment as Executive Chairman of the Board of The Mark Foundation for Cancer Research. DuBois is Chair and President of the AACR Foundation Board of Trustees; Past President of the AACR; Editor-in-Chief of Cancer Prevention Research, a journal of the AACR; and a Fellow of the AACR Academy.

“We are thrilled that The Mark Foundation has selected Dr. DuBois for this important new position,” said Margaret Foti, PhD, MD (hc), Chief Executive Officer of the AACR. “Dr. DuBois is highly respected among his peers as a forward-thinking and innovative leader in both cancer research and philanthropy. The AACR and the cancer research community as a whole have benefited greatly from the time and expertise he has contributed to the AACR over the years. The Mark Foundation has made an outstanding choice, and we look forward to continuing our work with Dr. DuBois and The Mark Foundation to advance cutting-edge cancer research and accelerate lifesaving progress for patients.”

Concurrently, The Mark Foundation announced that its founder Alex Knaster has committed to funding an additional $500 million to cutting-edge cancer research, in addition to $150 million already awarded by the Foundation since 2017. Operating on the premise that collaboration, flexibility, and agility are vital to enabling successful research, The Mark Foundation uses its team’s deep scientific and professional experience to identify and fund both academic research and early-stage biotech companies. As The Mark Foundation’s first Executive Chairman, DuBois will lead its board of directors as well as assume an executive role with the Foundation. He will also continue to serve in his current position as Director of the Medical University of South Carolina (MUSC) Hollings Cancer Center and Distinguished University Professor at MUSC.

DuBois is an internationally renowned expert known for his work elucidating the role of inflammation and inflammatory mediators in the progression of colon cancer and other gastrointestinal malignancies. He has until recently served as Dean of the MUSC College of Medicine, and he previously held leadership positions as Executive Director of the Biodesign Institute at Arizona State University with a joint clinical appointment at the Mayo Clinic; Provost and Executive Vice President at the University of Texas MD Anderson Cancer Center; and Director of the Vanderbilt-Ingram Cancer Center. In addition to being a Fellow of the AACR Academy, DuBois is a member of the National Academy of Medicine and a Fellow of the American Association for the Advancement of Science, the American Gastroenterology Association, and the Royal College of Physicians (London). As a renowned physician-scientist, he has published over 160 peer-reviewed research articles, more than 60 review articles, 25 book chapters, and three books.